GlobeNewsWire
18 Jun 2026, 19:34 UTC · 1h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
3 claims · each scored for market impact
CosmoFarm achieved record Q2 2026 revenue of over $15 million, representing an annualized run-rate exceeding $60 million. — Direct evidence of accelerating top-line growth and scale for a primary subsidiary.
+0.60CosmoFarm added more than 80 new pharmacies to its distribution network during the second quarter. — Rapid expansion of the customer base indicates strong market share gains and future revenue stability.
+0.40Cosmos Health is increasing capital expenditure to invest in robotic automation, AI systems, and facility expansion for CosmoFarm. — While increasing spending, these investments are aimed at improving margins and operational scalability.
+0.20Which stocks this story touches
Continue reading
6 related stories
Search tags
The company reported record revenue for its subsidiary CosmoFarm and is expanding its distribution network and automation capabilities.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Zacks Investment Research
3h ago
